Home Biosimilar Antibodies Cytoskeletal Signaling Integrin Tadocizumab (Anti-Integrin a2b3 (ITGA2 & ITGB3)) For research use only.
Not for use in humans.

Tadocizumab (Anti-Integrin a2b3 (ITGA2 & ITGB3))

Synonyms: C4G1; YM-337

Tadocizumab (Anti-Integrin a2b3 (ITGA2 & ITGB3)) is a humanized monoclonal antibody tageting integrin αIIbβ3. It has antiplatelet and antithrombotic effects, and can be used for cardiovascular disease research. MW :145.3 KD.

Tadocizumab (Anti-Integrin a2b3 (ITGA2 & ITGB3))

Purity & Quality Control

≥99

Choose Selective Integrin Inhibitors

Biological Activity

Description Tadocizumab (Anti-Integrin a2b3 (ITGA2 & ITGB3)) is a humanized monoclonal antibody tageting integrin αIIbβ3. It has antiplatelet and antithrombotic effects, and can be used for cardiovascular disease research. MW :145.3 KD.

Product Details

CAS No. 339086-80-5
Isotype Human IgG1
Source CHO
Formulation 100mMPro-Ac,20mMArg-Ac，pH5.0
Storage
(From the date of receipt)		 Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy Tadocizumab (Anti-Integrin a2b3 (ITGA2 & ITGB3)) | Tadocizumab (Anti-Integrin a2b3 (ITGA2 & ITGB3)) supplier | purchase Tadocizumab (Anti-Integrin a2b3 (ITGA2 & ITGB3)) | Tadocizumab (Anti-Integrin a2b3 (ITGA2 & ITGB3)) cost | Tadocizumab (Anti-Integrin a2b3 (ITGA2 & ITGB3)) manufacturer | order Tadocizumab (Anti-Integrin a2b3 (ITGA2 & ITGB3)) | Tadocizumab (Anti-Integrin a2b3 (ITGA2 & ITGB3)) distributor